Calcium channel blockers in systemic hypertension

1986 ◽  
Vol 58 (1) ◽  
pp. 157-160 ◽  
Author(s):  
William H. Frishman ◽  
Shlomo Charlap ◽  
Eric L. Michelson
1986 ◽  
Vol 57 (7) ◽  
pp. D22-D29 ◽  
Author(s):  
William H. Frishman ◽  
Shlomo Charlap ◽  
Bruce Kimmel ◽  
Jeffrey Goldberger ◽  
George Phillippides ◽  
...  

1987 ◽  
Vol 12 (5) ◽  
pp. 290-346 ◽  
Author(s):  
William H. Frishman ◽  
Jack A. Stroh ◽  
Steven M. Greenberg ◽  
Theresa Suarez ◽  
Adam Karp ◽  
...  

2011 ◽  
Vol 47 (5) ◽  
pp. 375-376 ◽  
Author(s):  
Marlene S. Pariser ◽  
Paul Berdoulay

A 3 yr old, 70 kg (154 lbs) female spayed Great Dane developed gingival hyperplasia after treatment of systemic hypertension with amlodipine 7.5 mg q 12 hr for 16 mo. Physical examination was unremarkable except for systemic hypertension and severe gingival hyperplasia. Amlodipine was replaced with hydralazine (0.72 mg/kg [0.32 mg/lb]). Nine months later, gingival hyperplasia was nearly resolved and hypertension was well controlled. Calcium channel blockers such as amlodipine are a rare cause of gingival hyperplasia in the canine patient. Recognition of this side effect is important because a full recovery can be achieved when the offending agent is removed.


2015 ◽  
Vol 21 (2) ◽  
pp. 237-241
Author(s):  
Dong Keun Kim ◽  
Jung Seok Kim ◽  
Ha Ram Yi ◽  
In Zoo Choi ◽  
Hyo Seung Ahn ◽  
...  

1988 ◽  
Vol 72 (2) ◽  
pp. 449-499 ◽  
Author(s):  
William H. Frishman ◽  
Jack A. Stroh ◽  
Steven Greenherg ◽  
Theresa Suarez ◽  
Adam Karp ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document